ACE and sarcoidosis: When comparing the serum levels of these markers between patients with sarcoidosis and those with nonsarcoidotic benign diseases, the levels of NSE, ACE, and sIL-2R were significantly higher in the sarcoidosis group (Figure 2(a)).